Octapharma Plasma, Inc. – FDA Inspection, Oct 25, 2023

Record Details

This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on October 25, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Octapharma Plasma, Inc.
Inspection Date: October 25, 2023
Product Type: Biologics
Office: Center for Biologics Evaluation and Research
People: Melsomar R. Ramos (Issuing Officer)
Paul M. Chefor (Investigator)

View Company Profile

ID · cbd3c99c-f875-4176-b149-cb518d9f1648

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number: 1221817
FDA center: Biologics
Project area: Blood and Blood Products

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Octapharma Plasma, Inc.

FDA Inspection

Octapharma Plasma, Inc.October 25, 2023